|

Sodium Thiosulfate Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: Cyanide Antidote Package, Disodium Thiosulfate, S-Hydril, Sodium Hyposulfate, Sodium Thiosulfate Pentahydrate +5 more

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • Columbia University1
  • Children's Oncology Group1

Indications

  • Cancer3
  • Peritoneal Carcinomatosis2
  • Atypical Mesothelial Proliferation1
  • Childhood Medulloblastoma1
  • Peritoneal Mesothelioma1

Birmingham, Alabama1 trial

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Hospital of Alabama

Phase 3

Bethesda, Maryland1 trial

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center

Phase 1

New York, New York1 trial

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Columbia University Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.